{"id":17479,"date":"2012-07-23T04:00:00","date_gmt":"2012-07-23T04:00:00","guid":{"rendered":"https:\/\/www.citizen.org\/article\/follow-up-letter-to-fda-regarding-lipotron-device\/"},"modified":"2019-05-22T17:32:09","modified_gmt":"2019-05-22T21:32:09","slug":"follow-up-letter-to-fda-regarding-lipotron-device","status":"publish","type":"article","link":"https:\/\/www.citizen.org\/article\/follow-up-letter-to-fda-regarding-lipotron-device\/","title":{"rendered":"Follow-Up Letter to FDA Regarding LipoTron Device"},"content":{"rendered":"<p><a href=\"https:\/\/www.citizen.org\/sites\/default\/files\/2047.pdf\">View as PDF.<\/a><\/p>\n<p><a href=\"https:\/\/www.citizen.org\/sites\/default\/files\/2044_attachments.pdf\">View attachments as a PDF.<\/a><\/p>\n<p>Public Citizen calls on the Food and Drug Administration to target Profit Solutions MD in addition to Advanced Aesthetic Concepts (AAC) for apparent illegal promotion of the unapproved LipoTron device because AAC and Profit Solutions MD are the same company. We recently recommended that the FDA immediately seize all LipoTron devices in the U.S. and order the manufacturer and its distributors to cease and desist all activities related to its distribution, sale, and promotion.<\/p>\n<p><a href=\"https:\/\/www.citizen.org\/sites\/default\/files\/aac_response.pdf\">August 3, 2012 letter from an attorney representing Advanced Aesthetic Concepts (AAC)<\/a>\u00a0&#8211; the distributor of the LipoTron device &#8211; demanding that Public Citizen cease and desist all communications about AAC\u2019s activities involving the marketing and promotion of the LipoTron device and threatening to file a lawsuit against Public Citizen unless it complied with this demand. (PDF)<\/p>\n<p><a href=\"https:\/\/www.citizen.org\/sites\/default\/files\/pc_response_to_aac.pdf\">August 22, 2012 letter from Public Citizen<\/a> rejecting the demand from AAC\u2019s attorney. (PDF)<\/p>\n ","protected":false},"parent":0,"template":"","meta":{"_acf_changed":false,"_links_to":"","_links_to_target":""},"class_list":["post-17479","article","type-article","status-publish","hentry","tax_topic-medical-devices","tax_type-letters-testimony-filings"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Follow-Up Letter to FDA Regarding LipoTron Device - Public Citizen<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.citizen.org\/article\/follow-up-letter-to-fda-regarding-lipotron-device\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Follow-Up Letter to FDA Regarding LipoTron Device - Public Citizen\" \/>\n<meta property=\"og:description\" content=\"Public Citizen calls on the Food and Drug Administration to target Profit Solutions MD in addition to Advanced Aesthetic Concepts (AAC) for apparent illegal promotion of the unapproved LipoTron device because AAC and Profit Solutions MD are the same company. We recently recommended that the FDA immediately seize all LipoTron devices in the U.S. and order the manufacturer and its distributors to cease and desist all activities related to its distribution, sale, and promotion.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.citizen.org\/article\/follow-up-letter-to-fda-regarding-lipotron-device\/\" \/>\n<meta property=\"og:site_name\" content=\"Public Citizen\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/publiccitizen\/\" \/>\n<meta property=\"article:modified_time\" content=\"2019-05-22T21:32:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.citizen.org\/wp-content\/uploads\/public_citizen_shared_link.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@Public_Citizen\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.citizen.org\/article\/follow-up-letter-to-fda-regarding-lipotron-device\/\",\"url\":\"https:\/\/www.citizen.org\/article\/follow-up-letter-to-fda-regarding-lipotron-device\/\",\"name\":\"Follow-Up Letter to FDA Regarding LipoTron Device - Public Citizen\",\"isPartOf\":{\"@id\":\"https:\/\/www.citizen.org\/#website\"},\"datePublished\":\"2012-07-23T04:00:00+00:00\",\"dateModified\":\"2019-05-22T21:32:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.citizen.org\/article\/follow-up-letter-to-fda-regarding-lipotron-device\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.citizen.org\/article\/follow-up-letter-to-fda-regarding-lipotron-device\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.citizen.org\/article\/follow-up-letter-to-fda-regarding-lipotron-device\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.citizen.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Articles\",\"item\":\"https:\/\/www.citizen.org\/article\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Follow-Up Letter to FDA Regarding LipoTron Device\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.citizen.org\/#website\",\"url\":\"https:\/\/www.citizen.org\/\",\"name\":\"Public Citizen\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.citizen.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Follow-Up Letter to FDA Regarding LipoTron Device - Public Citizen","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.citizen.org\/article\/follow-up-letter-to-fda-regarding-lipotron-device\/","og_locale":"en_US","og_type":"article","og_title":"Follow-Up Letter to FDA Regarding LipoTron Device - Public Citizen","og_description":"Public Citizen calls on the Food and Drug Administration to target Profit Solutions MD in addition to Advanced Aesthetic Concepts (AAC) for apparent illegal promotion of the unapproved LipoTron device because AAC and Profit Solutions MD are the same company. We recently recommended that the FDA immediately seize all LipoTron devices in the U.S. and order the manufacturer and its distributors to cease and desist all activities related to its distribution, sale, and promotion.","og_url":"https:\/\/www.citizen.org\/article\/follow-up-letter-to-fda-regarding-lipotron-device\/","og_site_name":"Public Citizen","article_publisher":"https:\/\/www.facebook.com\/publiccitizen\/","article_modified_time":"2019-05-22T21:32:09+00:00","og_image":[{"width":1200,"height":628,"url":"https:\/\/www.citizen.org\/wp-content\/uploads\/public_citizen_shared_link.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@Public_Citizen","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.citizen.org\/article\/follow-up-letter-to-fda-regarding-lipotron-device\/","url":"https:\/\/www.citizen.org\/article\/follow-up-letter-to-fda-regarding-lipotron-device\/","name":"Follow-Up Letter to FDA Regarding LipoTron Device - Public Citizen","isPartOf":{"@id":"https:\/\/www.citizen.org\/#website"},"datePublished":"2012-07-23T04:00:00+00:00","dateModified":"2019-05-22T21:32:09+00:00","breadcrumb":{"@id":"https:\/\/www.citizen.org\/article\/follow-up-letter-to-fda-regarding-lipotron-device\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.citizen.org\/article\/follow-up-letter-to-fda-regarding-lipotron-device\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.citizen.org\/article\/follow-up-letter-to-fda-regarding-lipotron-device\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.citizen.org\/"},{"@type":"ListItem","position":2,"name":"Articles","item":"https:\/\/www.citizen.org\/article\/"},{"@type":"ListItem","position":3,"name":"Follow-Up Letter to FDA Regarding LipoTron Device"}]},{"@type":"WebSite","@id":"https:\/\/www.citizen.org\/#website","url":"https:\/\/www.citizen.org\/","name":"Public Citizen","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.citizen.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.citizen.org\/wp-json\/wp\/v2\/article\/17479","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.citizen.org\/wp-json\/wp\/v2\/article"}],"about":[{"href":"https:\/\/www.citizen.org\/wp-json\/wp\/v2\/types\/article"}],"version-history":[{"count":0,"href":"https:\/\/www.citizen.org\/wp-json\/wp\/v2\/article\/17479\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.citizen.org\/wp-json\/wp\/v2\/media?parent=17479"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}